(Mark One) | |
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
France | 98-0667516 | |||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||
300 East Lombard Street, Suite 1710 | ||||||
Baltimore, | MD | |||||
21202 | ||||||
(Zip Code) | ||||||
(Address of principal executive office (US)) | ||||||
(443) | 420-7861 | |||||
(Registrant's telephone number, including area code) | ||||||
Securities registered pursuant to section 12(b) of the Act | ||||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||
Ordinary Shares | CSTM | New York Stock Exchange | ||||
Large accelerated filer | ☑ | Accelerated filer | ☐ | |
Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |
Emerging growth company | ☐ |
Page | |||
Item 1. | |||
Item 2. | |||
Item 3. | |||
Item 4. | |||
Item 1. | |||
Item 1A. | |||
Item 2. | |||
Item 3. | |||
Item 4. | |||
Item 5. | |||
Item 6. | |||
Three months ended June 30, | Six months ended June 30, | |||||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | 2026 | 2025 | |||||
Revenue | 2 | 2,748 | 2,103 | 5,209 | 4,082 | |||||
Cost of sales (excluding depreciation and amortization) | (2,268) | (1,840) | (4,309) | (3,556) | ||||||
Depreciation and amortization | (84) | (82) | (167) | (160) | ||||||
Selling and administrative expenses | (101) | (88) | (198) | (166) | ||||||
Research and development expenses | (14) | (12) | (27) | (25) | ||||||
Other gains and losses – net | 4 | (39) | 4 | 34 | (1) | |||||
Finance costs – net | 5 | (28) | (29) | (56) | (56) | |||||
Income before tax | 214 | 56 | 486 | 118 | ||||||
Income tax expense | 6 | (66) | (20) | (142) | (44) | |||||
Net income | 148 | 36 | 344 | 74 | ||||||
Attributable to: | ||||||||||
Equity holders of Constellium SE | 146 | 36 | 345 | 73 | ||||||
Non-controlling interests | 2 | — | (1) | 1 | ||||||
Net income | 148 | 36 | 344 | 74 | ||||||
Earnings per share attributable to the equity holders of Constellium SE (in U.S. dollars) | Notes | |||||||||
Basic | 7 | 1.07 | 0.25 | 2.54 | 0.51 | |||||
Diluted | 7 | 1.04 | 0.25 | 2.46 | 0.51 |
Three months ended June 30, | Six months ended June 30, | |||||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | 2026 | 2025 | |||||
Net income | 148 | 36 | 344 | 74 | ||||||
Other comprehensive (loss) / income | ||||||||||
Net change in post-employment benefit obligations | (4) | — | (9) | (3) | ||||||
Income tax on net change in post- employment benefit obligations | — | (1) | 1 | — | ||||||
Net change in cash flow hedges | 12 | (3) | 25 | (11) | 37 | |||||
Income tax on cash flow hedges | 1 | (7) | 3 | (10) | ||||||
Currency translation adjustments | (1) | 11 | (6) | 15 | ||||||
Other comprehensive (loss) / income | (7) | 28 | (22) | 39 | ||||||
Total comprehensive income | 141 | 64 | 322 | 113 | ||||||
Attributable to: | ||||||||||
Equity holders of Constellium SE | 139 | 63 | 323 | 111 | ||||||
Non-controlling interests | 2 | 1 | (1) | 2 | ||||||
Total comprehensive income | 141 | 64 | 322 | 113 | ||||||
(in millions of U.S. dollars) except share data and as otherwise stated | Notes | At June 30, 2026 | At December 31, 2025 | |||
Assets | ||||||
Current assets | ||||||
Cash and cash equivalents | 163 | 120 | ||||
Trade receivables and other, net | 8 | 1,167 | 723 | |||
Inventories | 9 | 1,877 | 1,407 | |||
Fair value of derivative instruments and other financial assets | 66 | 72 | ||||
Total current assets | 3,273 | 2,322 | ||||
Non-current assets | ||||||
Property, plant and equipment, net | 2,481 | 2,585 | ||||
Goodwill | 46 | 47 | ||||
Intangible assets, net | 82 | 88 | ||||
Deferred tax assets | 153 | 270 | ||||
Trade receivables and other, net | 8 | 33 | 31 | |||
Fair value of derivative instruments | 12 | 2 | 11 | |||
Total non-current assets | 2,797 | 3,032 | ||||
Total assets | 6,070 | 5,354 | ||||
Liabilities | ||||||
Current liabilities | ||||||
Trade payables and other | 10 | 2,104 | 1,674 | |||
Current portion of long-term debt | 11 | 42 | 39 | |||
Fair value of derivative instruments | 12 | 74 | 18 | |||
Income tax payable | 24 | 18 | ||||
Pension and other benefit obligations | 23 | 24 | ||||
Provisions | 14 | 23 | 25 | |||
Total current liabilities | 2,290 | 1,798 | ||||
Non-current liabilities | ||||||
Trade payables and other | 10 | 162 | 163 | |||
Long-term debt | 11 | 1,881 | 1,905 | |||
Fair value of derivative instruments | 12 | 4 | 3 | |||
Pension and other benefit obligations | 327 | 338 | ||||
Provisions | 14 | 92 | 106 | |||
Deferred tax liabilities | 60 | 70 | ||||
Total non-current liabilities | 2,526 | 2,585 | ||||
Total liabilities | 4,816 | 4,383 | ||||
Commitments and contingencies | 14 | |||||
Shareholders' equity | ||||||
Ordinary shares, par value €0.02, 146,819,884 shares issued at June 30, 2026 and at December 31, 2025; 135,527,728 and 135,424,702 shares outstanding at June 30, 2026 and at December 31, 2025, respectively | 4 | 4 | ||||
Additional paid in capital | 712 | 693 | ||||
Accumulated other comprehensive income | 15 | 34 | 54 | |||
Retained earnings | 673 | 354 | ||||
Treasury shares 11,292,156 at June 30, 2026 and 11,395,182 at December 31, 2025 | (177) | (153) | ||||
Equity attributable to equity holders of Constellium SE | 1,246 | 952 | ||||
Non-controlling interests | 8 | 19 | ||||
Total equity | 1,254 | 971 | ||||
Total equity and liabilities | 6,070 | 5,354 |
in millions of U.S. dollars, except share amounts | Ordinary shares outstanding | Ordinary shares | Treasury shares | Accumulated other comprehensive income / (loss) | Additional paid in capital | Retained earnings | Non- controlling interests | Total equity | ||||||||
At January 1, 2026 | 135,424,702 | 4 | (153) | 54 | 693 | 354 | 19 | 971 | ||||||||
Net income | — | — | — | — | — | 199 | (3) | 196 | ||||||||
Other comprehensive income | — | — | — | (15) | — | — | — | (15) | ||||||||
Total comprehensive income | — | — | — | (15) | — | 199 | (3) | 181 | ||||||||
Share-based compensation | — | — | — | — | 11 | — | — | 11 | ||||||||
Repurchase of ordinary shares | (1,152,075) | — | (28) | — | — | — | — | (28) | ||||||||
Allocation of treasury shares to share-based compensation plan vested | 1,877,823 | — | 24 | — | — | (24) | — | — | ||||||||
Transactions with non- controlling interests | — | — | — | — | — | — | (3) | (3) | ||||||||
At March 31, 2026 | 136,150,450 | 4 | (157) | 39 | 704 | 529 | 13 | 1,132 | ||||||||
Net income | — | — | — | — | — | 146 | 2 | 148 | ||||||||
Other comprehensive loss | — | — | — | (7) | — | — | — | (7) | ||||||||
Total comprehensive (loss) / income | — | — | — | (7) | — | 146 | 2 | 141 | ||||||||
Share-based compensation | — | — | — | — | 8 | — | — | 8 | ||||||||
Repurchase of ordinary shares | (622,722) | — | (20) | — | — | — | — | (20) | ||||||||
Allocation of treasury shares to share-based compensation plan vested | — | — | — | — | — | — | — | — | ||||||||
Other | — | — | — | 2 | — | (2) | (3) | (3) | ||||||||
Transactions with non- controlling interests | — | — | — | — | — | — | (4) | (4) | ||||||||
At June 30, 2026 | 135,527,728 | 4 | (177) | 34 | 712 | 673 | 8 | 1,254 | ||||||||
in millions of U.S. dollars, except share amounts | Ordinary shares outstanding | Ordinary shares | Treasury shares | Accumulated other comprehensive income / (loss) | Additional paid in capital | Retained earnings | Non- controlling interests | Total equity | ||||||||
At January 1, 2025 | 143,523,308 | 4 | (51) | (14) | 674 | 93 | 21 | 727 | ||||||||
Net income | — | — | — | — | — | 37 | 1 | 38 | ||||||||
Other comprehensive loss | — | — | — | 11 | — | — | — | 11 | ||||||||
Total comprehensive (loss) / income | — | — | — | 11 | — | 37 | 1 | 49 | ||||||||
Share-based compensation | — | — | — | — | 6 | — | — | 6 | ||||||||
Repurchase of ordinary shares | (1,421,058) | — | (15) | — | — | — | — | (15) | ||||||||
Allocation of treasury shares to share-based compensation plan vested | 815,749 | — | 12 | — | — | (12) | — | — | ||||||||
Other | — | — | — | 2 | — | (2) | — | — | ||||||||
Transactions with non- controlling interests | — | — | — | — | — | — | (2) | (2) | ||||||||
At March 31, 2025 | 142,917,999 | 4 | (54) | (1) | 680 | 116 | 20 | 765 | ||||||||
Net income | — | — | — | — | — | 36 | — | 36 | ||||||||
Other comprehensive income | — | — | — | 27 | — | — | 1 | 28 | ||||||||
Total comprehensive income | — | — | — | 27 | — | 36 | 1 | 64 | ||||||||
Share-based compensation | — | — | — | — | 7 | — | — | 7 | ||||||||
Repurchase of ordinary shares | (3,378,976) | — | (35) | — | — | — | — | (35) | ||||||||
Allocation of treasury shares to share-based compensation plan vested | — | — | — | — | — | — | — | — | ||||||||
Other | — | — | — | — | — | — | — | — | ||||||||
Transactions with non- controlling interests | — | — | — | — | — | — | (2) | (2) | ||||||||
At June 30, 2025 | 139,539,023 | 4 | (89) | 26 | 687 | 152 | 19 | 799 | ||||||||
Three months ended June 30, | Six months ended June 30, | |||||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | 2026 | 2025 | |||||
Net income | 148 | 36 | 344 | 74 | ||||||
Adjustments | ||||||||||
Depreciation and amortization | 3 | 84 | 82 | 167 | 160 | |||||
Impairment of assets | 3 | (1) | — | 3 | — | |||||
Pension and other long-term benefits | 5 | 2 | 7 | 4 | ||||||
Finance costs - net | 5 | 28 | 29 | 56 | 56 | |||||
Income tax expense | 66 | 20 | 142 | 44 | ||||||
Unrealized losses / (gains) on derivatives - net and from remeasurement of monetary assets and liabilities - net | 102 | (35) | 59 | (24) | ||||||
Losses on disposal | 4 | 1 | 1 | 1 | 1 | |||||
Other - net | 14 | 11 | 32 | 22 | ||||||
Changes in working capital | ||||||||||
Inventories | (216) | 4 | (495) | (65) | ||||||
Trade receivables | (169) | 12 | (418) | (261) | ||||||
Trade payables | 154 | (38) | 480 | 241 | ||||||
Other | 12 | 23 | (24) | 5 | ||||||
Change in provisions | (15) | (1) | (13) | (2) | ||||||
Pension and other long-term benefits paid | (11) | (12) | (25) | (25) | ||||||
Interest paid | (21) | (24) | (50) | (53) | ||||||
Income tax paid | (20) | 4 | (32) | (5) | ||||||
Net cash flows from operating activities | 161 | 114 | 234 | 172 | ||||||
Purchases of property, plant and equipment | 3 | (77) | (77) | (149) | (146) | |||||
Property, plant and equipment inflows | 3 | 6 | 4 | 10 | 12 | |||||
Collection of deferred purchase price receivable | 8 | — | — | — | 2 | |||||
Proceeds from disposals, net of cash | 2 | — | 2 | — | ||||||
Other investing activities | — | 1 | — | 1 | ||||||
Net cash flows used in investing activities | (69) | (72) | (137) | (131) | ||||||
Repurchase of ordinary shares | (20) | (35) | (48) | (50) | ||||||
Repayments of long-term debt | (1) | (2) | (2) | (3) | ||||||
Net change in revolving credit facilities and short- term debt | (46) | 23 | 4 | 28 | ||||||
Finance lease repayments | (2) | (1) | (4) | (3) | ||||||
Transactions with non-controlling interests | (2) | (2) | (6) | (4) | ||||||
Other financing activities | — | (19) | 5 | (30) | ||||||
Net cash flows used in financing activities | (71) | (36) | (51) | (62) | ||||||
Net increase / (decrease) in cash and cash equivalents | 21 | 6 | 46 | (21) | ||||||
Cash and cash equivalents - beginning of period | 143 | 118 | 120 | 141 | ||||||
Net increase / (decrease) in cash and cash equivalents | 21 | 6 | 46 | (21) | ||||||
Effect of exchange rate changes on cash and cash equivalents | (1) | 9 | (3) | 13 | ||||||
Cash and cash equivalents - end of period | 163 | 133 | 163 | 133 | ||||||
Three months ended June 30, | Six months ended June 30, | |||||||
(in millions of U.S. dollars) | 2026 | 2025 | 2026 | 2025 | ||||
Aerospace rolled products | 350 | 267 | 679 | 534 | ||||
Transportation, industry, defense and other rolled products | 288 | 200 | 543 | 368 | ||||
Packaging rolled products | 1,188 | 912 | 2,234 | 1,780 | ||||
Automotive rolled products | 454 | 295 | 857 | 586 | ||||
Specialty and other thin-rolled products | 31 | 26 | 56 | 50 | ||||
Automotive extruded products | 266 | 249 | 528 | 483 | ||||
Other extruded products | 171 | 154 | 312 | 281 | ||||
Total revenue | 2,748 | 2,103 | 5,209 | 4,082 | ||||
Three months ended June 30, | ||||||||||
2026 | 2025 | |||||||||
(in millions of U.S. dollars) | A&T | P&ARP | AS&I | H&C (B) | A&T | P&ARP | AS&I | H&C (B) | ||
Segment revenue | 680 | 1,680 | 458 | 2 | 492 | 1,235 | 421 | 1 | ||
Inter-segment elimination | (44) | (7) | (21) | — | (26) | (3) | (18) | — | ||
External revenue | 636 | 1,673 | 437 | 2 | 466 | 1,232 | 404 | 1 | ||
Cost of metal | (310) | (1,221) | (270) | 1 | (203) | (895) | (248) | 2 | ||
Production costs | (162) | (254) | (114) | (2) | (151) | (234) | (114) | (2) | ||
Other segment expenses (A) | (29) | (33) | (27) | (17) | (27) | (29) | (24) | (12) | ||
Segment Adjusted EBITDA | 135 | 165 | 26 | (16) | 84 | 74 | 18 | (12) | ||
Six months ended June 30, | ||||||||||
2026 | 2025 | |||||||||
(in millions of U.S. dollars) | A&T | P&ARP | AS&I | H&C (B) | A&T | P&ARP | AS&I | H&C (B) | ||
Segment revenue | 1,289 | 3,157 | 873 | 3 | 960 | 2,422 | 802 | 2 | ||
Inter-segment elimination | (70) | (10) | (33) | — | (60) | (6) | (38) | — | ||
External revenue | 1,219 | 3,147 | 840 | 3 | 900 | 2,416 | 764 | 2 | ||
Cost of metal | (590) | (2,260) | (507) | 3 | (388) | (1,753) | (462) | 3 | ||
Production costs | (335) | (508) | (231) | (3) | (296) | (474) | (221) | (4) | ||
Other segment expenses (A) | (56) | (62) | (53) | (35) | (50) | (54) | (47) | (24) | ||
Segment Adjusted EBITDA | 238 | 317 | 49 | (32) | 165 | 135 | 34 | (23) | ||
Three months ended June 30, | Six months ended June 30, | |||||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | 2026 | 2025 | |||||
A&T | 135 | 84 | 238 | 165 | ||||||
P&ARP | 165 | 74 | 317 | 135 | ||||||
AS&I | 26 | 18 | 49 | 34 | ||||||
H&C (A) | (16) | (12) | (32) | (23) | ||||||
Segment Adjusted EBITDA | 310 | 165 | 572 | 312 | ||||||
Metal price lag (B) | 129 | (19) | 226 | 20 | ||||||
Depreciation and amortization | (84) | (82) | (167) | (160) | ||||||
Impairment of assets | 1 | — | (3) | — | ||||||
Share based compensation | 16 | (8) | (7) | (19) | (13) | |||||
Pension and other post-employment benefits - non-operating gains | 4 | 4 | 7 | 7 | ||||||
Restructuring costs | (2) | (1) | (5) | (2) | ||||||
Unrealized (losses) / gains on derivatives | (102) | 33 | (60) | 21 | ||||||
Unrealized exchange gains / (losses) from the remeasurement of monetary assets and liabilities – net | — | 1 | 1 | — | ||||||
Losses on disposal | (1) | (1) | (1) | (1) | ||||||
Other (C) | — | (2) | — | 1 | ||||||
Expenses on factoring arrangements | 8 | (5) | (6) | (9) | (11) | |||||
Finance costs – net | 5 | (28) | (29) | (56) | (56) | |||||
Income before tax | 214 | 56 | 486 | 118 | ||||||
Income tax expense | 6 | (66) | (20) | (142) | (44) | |||||
Net income | 148 | 36 | 344 | 74 | ||||||
Three months ended June 30, | Six months ended June 30, | |||||||
(in millions of U.S. dollars) | 2026 | 2025 | 2026 | 2025 | ||||
A&T | (17) | (16) | (27) | (29) | ||||
P&ARP | (44) | (41) | (92) | (75) | ||||
AS&I | (8) | (15) | (18) | (29) | ||||
H&C (A) | (2) | (1) | (2) | (1) | ||||
Total capital expenditures (B) | (71) | (73) | (139) | (134) | ||||
Three months ended June 30, | Six months ended June 30, | |||||||
(in millions of U.S. dollars) | 2026 | 2025 | 2026 | 2025 | ||||
A&T | (19) | (18) | (37) | (35) | ||||
P&ARP | (48) | (45) | (95) | (89) | ||||
AS&I | (15) | (17) | (35) | (33) | ||||
H&C (A) | (1) | (2) | (3) | (3) | ||||
Total depreciation, amortization and impairment expense | (83) | (82) | (170) | (160) | ||||
(in millions of U.S. dollars) | At June 30, 2026 | At December 31, 2025 | ||
A&T | 1,628 | 1,375 | ||
P&ARP | 2,806 | 2,405 | ||
AS&I | 722 | 711 | ||
H&C (A) | 530 | 390 | ||
Deferred income tax assets | 153 | 270 | ||
Cash and cash equivalents | 163 | 120 | ||
Fair value of derivative instruments and other financial assets | 68 | 83 | ||
Total assets | 6,070 | 5,354 |
Three months ended June 30, | Six months ended June 30, | |||||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | 2026 | 2025 | |||||
Operating income and expenses | ||||||||||
Realized gains / (losses) on derivatives (A) | 66 | (25) | 104 | (19) | ||||||
Unrealized (losses) / gains on derivatives at fair value through profit and loss - net (A) | 12 | (102) | 33 | (60) | 21 | |||||
Unrealized exchange gains / (losses) from the remeasurement of monetary assets and liabilities – net | — | 1 | 1 | — | ||||||
Impairment of assets | 1 | — | (3) | — | ||||||
Restructuring costs | (2) | (1) | (5) | (2) | ||||||
Losses on disposal | (1) | (1) | (1) | (1) | ||||||
Result from the flood in Valais | 3 | — | (2) | — | 2 | |||||
Non-operating income and expenses | ||||||||||
Expenses on factoring arrangements | 8 | (5) | (6) | (9) | (11) | |||||
Pension and other post-employment benefits | 13 | 4 | 4 | 7 | 7 | |||||
Other | — | 1 | — | 2 | ||||||
Total other gains and losses - net | (39) | 4 | 34 | (1) | ||||||
Three months ended June 30, | Six months ended June 30, | |||||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | 2026 | 2025 | |||||
Interest expense on borrowings (A) | (26) | (25) | (52) | (50) | ||||||
Interest expense on finance leases | (1) | (1) | (1) | (1) | ||||||
Interest cost on pension and other long-term benefits | 13 | (2) | (2) | (4) | (4) | |||||
Realized and unrealized (losses) / gains on debt derivatives at fair value (B) | 12 | (4) | (17) | 1 | (26) | |||||
Realized and unrealized exchange gains / (losses) on financing activities - net (B) | 4 | 18 | — | 28 | ||||||
Other finance expenses | (1) | (3) | (3) | (5) | ||||||
Capitalized borrowing costs (C) | 2 | 1 | 3 | 2 | ||||||
Finance expenses | (28) | (29) | (56) | (56) | ||||||
Finance costs - net | (28) | (29) | (56) | (56) | ||||||
Three months ended June 30, | Six months ended June 30, | |||||||
(in millions of U.S. dollars except share and per share amounts ) | 2026 | 2025 | 2026 | 2025 | ||||
Numerator: | ||||||||
Net income attributable to equity holders of Constellium SE | 146 | 36 | 345 | 73 | ||||
Denominator: | ||||||||
Basic - weighted-average ordinary shares outstanding | 135,866,171 | 140,820,828 | 135,633,294 | 141,665,123 | ||||
Dilutive effect of non-vested restricted stock units and performance-based restricted stock units | 4,287,582 | 1,423,571 | 4,488,781 | 1,508,801 | ||||
Diluted - weighted-average ordinary shares, of restricted stock units and performance-based restricted stock units | 140,153,753 | 142,244,399 | 140,122,075 | 143,173,924 | ||||
Basic earnings per share | $1.07 | $0.25 | $2.54 | $0.51 | ||||
Diluted earnings per share | $1.04 | $0.25 | $2.46 | $0.51 | ||||
At June 30, 2026 | At December 31, 2025 | |||
(in millions of U.S. dollars) | Current | Current | ||
Trade receivables - gross | 1,020 | 614 | ||
Allowance for credit losses | (4) | (3) | ||
Total trade receivables - net | 1,016 | 611 | ||
Total other receivables | 151 | 112 | ||
Total trade receivables and other | 1,167 | 723 |
(in millions of U.S. dollars) | At June 30, 2026 | At December 31, 2025 | ||
Finished goods | 306 | 324 | ||
Work in progress | 951 | 625 | ||
Raw materials | 519 | 356 | ||
Stores and supplies | 101 | 102 | ||
Total inventories | 1,877 | 1,407 |
At June 30, 2026 | At December 31, 2025 | |||
(in millions of U.S. dollars) | Current | Current | ||
Trade payables | 1,659 | 1,222 | ||
Employees' entitlements | 265 | 268 | ||
Other payables | 180 | 184 | ||
Total other | 445 | 452 | ||
Total trade payables and other | 2,104 | 1,674 |
Six months ended June 30, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
Contract liabilities and other liabilities to customers at January 1, | 113 | 98 | ||
Revenue deferred to contract liabilities | 19 | 20 | ||
Revenue recognized from contract liabilities | (19) | (22) | ||
Effect of changes in foreign currency rates and other changes | (5) | 8 | ||
Contract liabilities and other liabilities to customers at June 30, | 108 | 104 | ||
At June 30, 2026 | At December 31, 2025 | |||||||||
(in millions of U.S. dollars) | Nominal Value in Currency | Nominal rate | Effective rate | Face Value | Debt issuance costs | Accrued interest | Carrying value | Carrying value | ||
Secured Pan-U.S. ABL (due 2029) | $— | Floating | 5.08% | — | — | 1 | 1 | — | ||
Senior Unsecured Notes | ||||||||||
Issued June 2020 and due 2028 | $325 | 5.625% | 6.05% | 325 | (2) | 1 | 324 | 323 | ||
Issued February 2021 and due 2029 | $500 | 3.750% | 4.05% | 500 | (3) | 4 | 501 | 500 | ||
Issued June 2021 and due 2029 | €300 | 3.125% | 3.41% | 342 | (2) | 4 | 344 | 355 | ||
Issued August 2024 and due 2032 | $350 | 6.375% | 6.77% | 350 | (5) | 8 | 353 | 353 | ||
Issued August 2024 and due 2032 | €300 | 5.375% | 5.73% | 342 | (5) | 7 | 344 | 354 | ||
Finance lease liabilities | 28 | — | 1 | 29 | 32 | |||||
Other loans | 27 | — | — | 27 | 27 | |||||
Total debt | 1,914 | (17) | 26 | 1,923 | 1,944 | |||||
Of which non-current | 1,881 | 1,905 | ||||||||
Of which current (A) | 42 | 39 | ||||||||
At June 30, 2026 | At December 31, 2025 | |||||||||||
(in millions of U.S. dollars) | Non- current | Current | Total | Non- current | Current | Total | ||||||
Derivatives that qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | 1 | 1 | 2 | 7 | 6 | 13 | ||||||
Derivatives that do not qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | — | 6 | 6 | 3 | 7 | 10 | ||||||
Energy derivatives | 1 | — | 1 | 1 | 1 | 2 | ||||||
Metal derivatives | — | 59 | 59 | — | 58 | 58 | ||||||
Fair value of derivative instruments - assets | 2 | 66 | 68 | 11 | 72 | 83 | ||||||
Derivatives that qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | 1 | 1 | 2 | — | — | — | ||||||
Derivatives that do not qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | 1 | 12 | 13 | 1 | 4 | 5 | ||||||
Energy derivatives | 2 | 4 | 6 | 1 | 2 | 3 | ||||||
Metal derivatives | — | 57 | 57 | 1 | 12 | 13 | ||||||
Fair value of derivative instruments - liabilities | 4 | 74 | 78 | 3 | 18 | 21 | ||||||
At June 30, 2026 | At December 31, 2025 | |||||||||||||||
(in millions of U.S. dollars) | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | ||||||||
Fair value of derivative instruments - assets | 35 | 33 | — | 68 | 32 | 51 | — | 83 | ||||||||
Fair value of derivative instruments - liabilities | 39 | 39 | — | 78 | 5 | 16 | — | 21 | ||||||||
Sold currencies | Maturity Year | Less than 1 year | Over 1 year | |||
USD | 2026-2031 | 526 | 289 | |||
CHF | 2026-2030 | 71 | 9 | |||
CZK | 2026 | — | — | |||
Other currencies | 2026-2027 | 9 | — |
Purchased currencies | ||||||
USD | 2026-2027 | 126 | 2 | |||
CHF | 2026-2030 | 148 | 17 | |||
CZK | 2026-2027 | 68 | — | |||
Other currencies | 2026 | 6 | — |
Three months ended June 30, | Six months ended June 30, | |||||||
(in millions of U.S. dollars) | 2026 | 2025 | 2026 | 2025 | ||||
Derivatives that do not qualify for hedge accounting | ||||||||
Included in Other gains and losses - net | ||||||||
Realized gains on foreign currency derivatives - net (A) | (1) | 3 | — | — | ||||
Unrealized (losses) / gains on foreign currency derivatives - net (B) | (2) | 23 | (14) | 38 | ||||
Derivatives that qualify for hedge accounting | ||||||||
Included in Other comprehensive income | ||||||||
Unrealized (losses) / gains on foreign currency derivatives - net | (2) | 26 | (9) | 37 | ||||
(Losses) / gains reclassified from cash flow hedge reserve to the Consolidated Income Statement | (1) | (1) | (2) | — | ||||
Included in Revenue (C) | ||||||||
Realized gains / (losses) on foreign currency derivatives - net (A) | 1 | (1) | 3 | (4) | ||||
Unrealized (losses) / gains on foreign currency derivatives - net | (1) | 1 | (1) | 3 | ||||
Three months ended June 30, | Six months ended June 30, | |||||||
(in millions of U.S. dollars) | 2026 | 2025 | 2026 | 2025 | ||||
Derivatives that do not qualify for hedge accounting | ||||||||
Included in Finance costs - net | ||||||||
Realized gains / (losses) on foreign currency derivatives - net (A) | (2) | (16) | 2 | (25) | ||||
Unrealized losses on foreign currency derivatives - net | (2) | (1) | (1) | (1) | ||||
Total | (4) | (17) | 1 | (26) | ||||
(in millions of U.S. dollars) | Maturity Year | Less than 1 year | Over 1 year | |||
Metal | 2026-2028 | 401 | 5 | |||
Natural gas | 2026-2029 | 28 | 29 |
Three months ended June 30, | Six months ended June 30, | |||||||
(in millions of U.S. dollar) | 2026 | 2025 | 2026 | 2025 | ||||
Derivatives that do not qualify for hedge accounting | ||||||||
Included in Other gains and losses - net | ||||||||
Realized gains / (losses) on commodities derivatives - net (A) | 67 | (28) | 104 | (19) | ||||
Unrealized (losses) / gains on commodities derivatives - net | (100) | 10 | (46) | (17) | ||||
Three months ended June 30, | Six months ended June 30, | ||||||||||||
2026 | 2025 | 2026 | 2025 | ||||||||||
(in millions of U.S. dollars) | Pension | OPEB and Other Benefits | Pension | OPEB and Other Benefits | Pension | OPEB and Other Benefits | Pension | OPEB and Other Benefits | |||||
Current service cost | (4) | (2) | (5) | (1) | (8) | (3) | (9) | (2) | |||||
Interest cost | (7) | (1) | (5) | (2) | (13) | (3) | (11) | (4) | |||||
Expected return on plan assets | 6 | — | 5 | — | 12 | — | 11 | — | |||||
Immediate recognition of losses arising over the year | — | (4) | — | — | — | (4) | — | — | |||||
Amortization of past service gain | 1 | 2 | 1 | 2 | 1 | 5 | 1 | 5 | |||||
Amortization of net actuarial gain | — | 1 | — | 1 | — | 1 | — | 1 | |||||
Total net pension and other long- term benefit cost | (4) | (4) | (4) | — | (8) | (4) | (8) | — | |||||
At June 30, 2026 | At December 31, 2025 | |||||||
(in millions of U.S. dollars) | Current | Non-current | Current | Non-current | ||||
Close down and environmental remediation costs | 14 | 74 | 13 | 85 | ||||
Restructuring costs | 4 | — | 1 | — | ||||
Legal claims and other costs | 5 | 18 | 11 | 21 | ||||
Total provisions | 23 | 92 | 25 | 106 | ||||
Three months ended June 30, 2026 | ||||||||
(in millions of U.S. dollars) | Post- employment benefit plans | Cash flow hedges | Currency translation adjustments | Accumulated other comprehensive income / (loss) | ||||
At March 31, 2026 | 111 | 2 | (74) | 39 | ||||
Other comprehensive income / (loss) before reclassification | (1) | (1) | (1) | (3) | ||||
Amounts reclassified from accumulated other comprehensive income / (loss) to the income statement | (3) | (1) | — | (4) | ||||
Amounts reclassified from accumulated other comprehensive income / (loss) to retained earnings | — | — | 2 | 2 | ||||
At June 30, 2026 | 107 | — | (73) | 34 | ||||
Three months ended June 30, 2025 | ||||||||
(in millions of U.S. dollars) | Post- employment benefit plans | Cash flow hedges | Currency translation adjustments | Accumulated other comprehensive income / (loss) | ||||
At March 31, 2025 | 82 | (5) | (78) | (1) | ||||
Other comprehensive income / (loss) before reclassification | 2 | 19 | 10 | 31 | ||||
Amounts reclassified from accumulated other comprehensive income / (loss) to the income statement | (3) | (1) | — | (4) | ||||
At June 30, 2025 | 81 | 13 | (68) | 26 | ||||
Six months ended June 30, 2026 | ||||||||
(in millions of U.S. dollars) | Post- employment benefit plans | Cash flow hedges | Currency translation adjustments | Accumulated other comprehensive income / (loss) | ||||
At January 1, 2026 | 115 | 8 | (69) | 54 | ||||
Other comprehensive income / (loss) before reclassification | (2) | (6) | (6) | (14) | ||||
Amounts reclassified from accumulated other comprehensive income / (loss) to the income statement | (6) | (2) | — | (8) | ||||
Amounts reclassified from accumulated other comprehensive income / (loss) to retained earnings | — | — | 2 | 2 | ||||
At June 30, 2026 | 107 | — | (73) | 34 | ||||
Six months ended June 30, 2025 | ||||||||
(in millions of U.S. dollars) | Post- employment benefit plans | Cash flow hedges | Currency translation adjustments | Accumulated other comprehensive income / (loss) | ||||
At January 1, 2025 | 84 | (14) | (84) | (14) | ||||
Other comprehensive income / (loss) before reclassification | 2 | 27 | 14 | 43 | ||||
Amounts reclassified from accumulated other comprehensive income / (loss) to the income statement | (5) | — | — | (5) | ||||
Amounts reclassified from accumulated other comprehensive income / (loss) to retained earnings | — | — | 2 | 2 | ||||
At June 30, 2025 | 81 | 13 | (68) | 26 | ||||
2026 PSUs | ||
Fair value at grant date (in U.S. dollars) | 34.38 | |
Share price at grant date (in U.S. dollars) | 24.59 | |
Dividend yield | — | |
Expected volatility (A) | 46% | |
Risk-free interest rate (U.S. government bond yield) | 3.75% |
Three months ended June 30, 2026 | Six months ended June 30, 2026 | |||||||
(as a % of total) | Revenue | Segment Adjusted EBITDA | Revenue | Segment Adjusted EBITDA | ||||
A&T | 25% | 44% | 25% | 42% | ||||
P&ARP | 61% | 53% | 61% | 55% | ||||
AS&I | 17% | 8% | 17% | 9% | ||||
H&C (1) | —% | (5)% | —% | (6)% | ||||
Total | 100% | 100% | 100% | 100% | ||||
Three months ended June 30, | Six months ended June 30, | Percent changes QTD | Percent changes YTD | |||||||||
(U.S. dollars per ton) | 2026 | 2025 | 2026 | 2025 | 2026 vs 2025 | 2026 vs 2025 | ||||||
Average LME transaction price | 3,571 | 2,448 | 3,382 | 2,539 | 46% | 33% | ||||||
Average Midwest premium | 2,518 | 990 | 2,405 | 849 | 154% | 183% | ||||||
Average all-in aluminum price U.S. | 6,089 | 3,438 | 5,787 | 3,388 | 77% | 71% | ||||||
Average LME transaction price | 3,571 | 2,448 | 3,382 | 2,539 | 46% | 33% | ||||||
Average Rotterdam premium | 581 | 195 | 485 | 244 | 198% | 99% | ||||||
Average all-in aluminum price Europe | 4,152 | 2,643 | 3,867 | 2,783 | 57% | 39% | ||||||
Three months ended June 30, | Six months ended June 30, | |||||||||||||||
(in millions of U.S. dollars and as a % of revenue) | 2026 | 2025 | 2026 | 2025 | ||||||||||||
Revenue | 2,748 | 100% | 2,103 | 100% | 5,209 | 100% | 4,082 | 100% | ||||||||
Cost of sales (excluding depreciation and amortization) | (2,268) | 83% | (1,840) | 87% | (4,309) | 83% | (3,556) | 87% | ||||||||
Depreciation and amortization | (84) | 3% | (82) | 4% | (167) | 3% | (160) | 4% | ||||||||
Selling and administrative expenses | (101) | 4% | (88) | 4% | (198) | 4% | (166) | 4% | ||||||||
Research and development expenses | (14) | 1% | (12) | 1% | (27) | 1% | (25) | 1% | ||||||||
Other gains and losses – net | (39) | 1% | 4 | —% | 34 | 1% | (1) | —% | ||||||||
Finance costs – net | (28) | 1% | (29) | 1% | (56) | 1% | (56) | 1% | ||||||||
Income before tax | 214 | 8% | 56 | 3% | 486 | 9% | 118 | 3% | ||||||||
Income tax expense | (66) | 2% | (20) | 1% | (142) | 3% | (44) | 1% | ||||||||
Net income | 148 | 5% | 36 | 2% | 344 | 7% | 74 | 2% | ||||||||
Shipment volumes (in kt) | 381 | n/a | 384 | n/a | 751 | n/a | 756 | n/a | ||||||||
Three months ended June 30, | Six months ended June 30, | |||||||
(in millions of U.S. dollars) | 2026 | 2025 | 2026 | 2025 | ||||
Realized (losses) / gains on foreign currency derivatives - net | (1) | 3 | — | — | ||||
Realized gains / (losses) on commodities derivatives - net | 67 | (28) | 104 | (19) | ||||
Realized gains / (losses) on derivatives | 66 | (25) | 104 | (19) | ||||
Unrealized (losses) / gains on foreign currency derivatives - net | (2) | 23 | (14) | 38 | ||||
Unrealized (losses) / gains on commodities derivatives - net | (100) | 10 | (46) | (17) | ||||
Unrealized (losses) / gains on derivatives at fair value through profit and loss - net | (102) | 33 | (60) | 21 | ||||
Three months ended June 30, | Six months ended June 30, | |||||||||||||||
(in millions of U.S. dollars and as a % of revenue) | 2026 | 2025 | 2026 | 2025 | ||||||||||||
A&T | 680 | 25% | 492 | 23% | 1,289 | 25% | 960 | 24% | ||||||||
P&ARP | 1,680 | 61% | 1,235 | 59% | 3,157 | 61% | 2,422 | 59% | ||||||||
AS&I | 458 | 17% | 421 | 20% | 873 | 17% | 802 | 20% | ||||||||
H&C (1) | 2 | —% | 1 | —% | 3 | —% | 2 | —% | ||||||||
Inter-segment eliminations | (72) | n.m | (46) | n.m | (113) | n.m | (104) | n.m | ||||||||
Total revenue | 2,748 | 100% | 2,103 | 100% | 5,209 | 100% | 4,082 | 100% | ||||||||
Three months ended June 30, | Six months ended June 30, | |||||||||||||||
(in kt and as a % of shipments) | 2026 | 2025 | 2026 | 2025 | ||||||||||||
A&T | 65 | 17% | 53 | 14% | 125 | 17% | 104 | 14% | ||||||||
P&ARP | 266 | 70% | 276 | 72% | 527 | 70% | 545 | 72% | ||||||||
AS&I | 55 | 14% | 55 | 14% | 105 | 14% | 107 | 14% | ||||||||
Inter-segment eliminations | (4) | n.m | — | n.m | (6) | n.m | — | n.m | ||||||||
Total shipments | 381 | 100% | 384 | 100% | 751 | 100% | 756 | 100% | ||||||||
Three months ended June 30, | Six months ended June 30, | |||||||||||||||
(in millions of U.S. dollars and as a % of revenue) | 2026 | 2025 | 2026 | 2025 | ||||||||||||
A&T | 135 | 20% | 84 | 17% | 238 | 18% | 165 | 17% | ||||||||
P&ARP | 165 | 10% | 74 | 6% | 317 | 10% | 135 | 6% | ||||||||
AS&I | 26 | 6% | 18 | 4% | 49 | 6% | 34 | 4% | ||||||||
(in millions of U.S. dollars) | A&T | P&ARP | AS&I | |||
Segment Adjusted EBITDA for the three months ended June 30, 2025 | 84 | 74 | 18 | |||
Volume | 40 | (5) | — | |||
Price and product mix | 16 | 20 | (5) | |||
Costs | (7) | 74 | 12 | |||
Foreign exchange and other | 2 | 2 | 1 | |||
Segment Adjusted EBITDA for the three months ended June 30, 2026 | 135 | 165 | 26 | |||
(in millions of U.S. dollars) | A&T | P&ARP | AS&I | |||
Segment Adjusted EBITDA for the six months ended June 30, 2025 | 165 | 135 | 34 | |||
Volume | 72 | (11) | (4) | |||
Price and product mix | 15 | 47 | (7) | |||
Costs | (23) | 138 | 23 | |||
Foreign exchange and other | 9 | 8 | 3 | |||
Segment Adjusted EBITDA for the six months ended June 30, 2026 | 238 | 317 | 49 |
Six months ended June 30, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
Net Cash Flows from / (used in) | ||||
Operating activities | 234 | 172 | ||
Investing activities | (137) | (131) | ||
Financing activities | (51) | (62) | ||
Net increase / (decrease) in cash and cash equivalents, excluding the effect of exchange rate changes | 46 | (21) | ||
Three months ended June 30, | Six months ended June 30, | |||||||
(in millions of U.S. dollars) | 2026 | 2025 | 2026 | 2025 | ||||
Net income | 148 | 36 | 344 | 74 | ||||
Income tax expense | 66 | 20 | 142 | 44 | ||||
Finance costs – net | 28 | 29 | 56 | 56 | ||||
Expenses on factoring arrangements | 5 | 6 | 9 | 11 | ||||
Depreciation and amortization | 84 | 82 | 167 | 160 | ||||
Restructuring costs | 2 | 1 | 5 | 2 | ||||
Unrealized gains on derivatives | 102 | (33) | 60 | (21) | ||||
Unrealized exchange gains from the remeasurement of monetary assets and liabilities – net | — | (1) | (1) | — | ||||
Pension and other post-employment benefits - non- operating gains | (4) | (4) | (7) | (7) | ||||
Share based compensation | 8 | 7 | 19 | 13 | ||||
Losses on disposal | 1 | 1 | 1 | 1 | ||||
Other (A) | — | 2 | — | (1) | ||||
Adjusted EBITDA1 | 439 | 146 | 798 | 332 | ||||
of which Metal price lag (B) | 129 | (19) | 226 | 20 | ||||
Period | Total number of shares purchased | Average price paid per share (in U.S. dollars) | Total number of shares purchased as part of publicly announced plans or programs | Maximum approximate dollar value of shares that may yet be purchased under the program | ||||
April 1 - April 30, 2026 | 241,155 | 29.74 | 241,155 | 71,669,820 | ||||
May 1 - May 31, 2026(1) | — | — | — | 300,000,000 | ||||
June 1 - June 30, 2026(2) | 381,567 | 34.07 | 381,567 | 287,000,029 | ||||
Total | 622,722 | 622,722 | 287,000,029 |
Exhibit | Description |
31.1 | |
31.2 | |
32.1 | |
32.2 | |
101.INS | Inline XBRL Instance Document** |
101.SCH | Inline XBRL Taxonomy Extension Schema Document** |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document** |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document** |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document** |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document** |
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)** |
Constellium SE | |||
Date: | July 29, 2026 | By: | /s/ Ingrid Joerg |
Name: Ingrid Joerg | |||
Title: Chief Executive Officer and Director | |||
Date: | July 29, 2026 | By: | /s/ Jack Guo |
Name: Jack Guo | |||
Title: Executive Vice President & Chief Financial Officer |